Health Care & Life Sciences » Pharmaceuticals | Enzon Pharmaceuticals Inc.

Enzon Pharmaceuticals Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
34,493.00
31,173.00
17,456.00
8,377.00
8,379.00
6,918
Cost of Goods Sold (COGS) incl. D&A
232.00
-
-
-
-
-
Gross Income
34,261.00
-
-
-
-
-
SG&A Expense
11,326.00
2,383.00
2,150.00
1,679.00
1,371.00
1,063
EBIT
22,935.00
28,790.00
15,306.00
6,698.00
7,008.00
5,855
Unusual Expense
4,776.00
-
4,506.00
54.00
-
-
Non Operating Income/Expense
1,853.00
61.00
-
-
-
-
Interest Expense
2,124.00
-
-
-
-
-
Pretax Income
18,122.00
28,851.00
10,800.00
6,644.00
7,008.00
5,855
Income Tax
28.00
56.00
10,837.00
7,770.00
1,563.00
6
Consolidated Net Income
18,150.00
28,795.00
21,637.00
1,126.00
5,445.00
5,849
Net Income
18,150.00
28,795.00
21,637.00
1,126.00
5,445.00
5,849
Net Income After Extraordinaries
18,150.00
28,795.00
21,637.00
1,126.00
5,445.00
5,849
Net Income Available to Common
18,150.00
28,795.00
21,637.00
1,126.00
5,445.00
5,849
EPS (Basic)
0.36
0.65
0.49
0.03
0.12
0.13
Basic Shares Outstanding
43,782.00
44,125.00
44,197.00
44,215.00
44,215.00
44,215
EPS (Diluted)
0.36
0.65
0.49
0.03
0.12
0.13
Diluted Shares Outstanding
51,045.00
44,245.00
44,220.00
44,215.00
44,215.00
44,215
EBITDA
23,167.00
28,790.00
15,306.00
6,698.00
7,008.00
-
Non-Operating Interest Income
234.00
-
-
-
-
-

About Enzon Pharmaceuticals

View Profile
Address
20 Commerce Drive
Cranford New Jersey 07016
United States
Employees -
Website http://www.enzon.com
Updated 07/08/2019
Enzon Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the provision of licensing arrangements related to sales of drug products that utilize its proprietary technology. The company was founded on September 17, 1981 and is headquartered in Cranford, NJ. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.